Anti-retroviral Treatment Related Haematological Disorders among HIV- Infected Children Attending HIV Clinic at Yekatit 12 Hospital, Addis Ababa, Ethiopia
Journal Title: International Blood Research & Reviews - Year 2015, Vol 4, Issue 2
Abstract
Background: The Management of drug toxicities is increasingly becoming a crucial component of human immunodeficiency virus infection and improvement of antiretroviral therapy in developing countries like Ethiopia. The severity of hematological abnormalities in children who are taking ART is not known well in Ethiopian Hospitals. Objective: The study was undertaken to determine the severity of HAART related hematological disorders in HIV positive children who were on HAART at Yekatit 12 Hospital, Addis Ababa, Ethiopia. Methods: A cross sectional study was conducted from May 2012 to February 2013 among children who had been on HAART for maximum of twelve months. Data collection using questionnaires and measurement of complete blood count and CD4 + T cell counts were made by using standard methodology. The results were tested using appropriate statistical methods (mean, Standard Deviation, Odd Ratio, p-value and F test value). Results: A total of 106 patients (<18 years) were enrolled in the study and had a mean age of 6.5±3.4 years, a median age of 7 years and female to male ratio of 1.04:1. The prevalence of anemia was 18.9%, 12.3% and 10.4% at baseline, at six months, and at twelve months post-treatment, respectively. Their mean hemoglobin level increased by 1.0 gm/dl at six months and by 1.7 gm/dl at twelve months of follow up with statistically significant values (p <0.001), and F test value presented 15.87. Patients who were put on AZT based regimen were more likely to develop anemia than those on D4T-based regimen, (OR=4.5, p-value <0.05). The prevalence of thrombocytopenia at baseline was 8.5%, but it was lowered for both at six and twelve months by 5.7%. The thrombocyte count of AZT based regimen showed statistically significant association (p- <0.05) and F test value as 2.98. The prevalence of neutropenia at baseline and at six months was similar with the value of 2.8% while at twelve months it was higher at 5.7%. Conclusion: Anemia, neutropenia and thrombocytopenia were the hematological abnormalities among HIV infected Ethiopian children taking HAART. Anemia was the most common abnormality, but significantly lesser than in many other hospitals in Ethiopia and among those who were on AZT based regimen. It is recommended that even in limited laboratory monitoring, HAART can be safely used and health professionals may consider other risk factors associated with the development of cytopenia before selection of second line of HAART drug regimen.
Authors and Affiliations
M. K. C. Menon, Mestewat Debasu, Yididya Belayneh, Workeabeba Abebe, Degu Jerene, Daniel Seifu
Keywords
Related Articles
- EP ID EP242557
- DOI 10.9734/IBRR/2015/20197
- Views 106
- Downloads 0
An Immunohistochemical Study of PRAME Expression in Non-hodgkin’s Lymphoma
Aim: Preferentially expressed antigen of melanoma (PRAME) is a cancer-testis antigen with very low/no expression in normal tissues. PRAME is an important target for tumor immunotherapy. Prognostic and in some tumors pred...
Newly Exposed Membrane Glycoprotein II β (CD41) on Activated Platelets has Higher Affinity for Plasma Fibrinogen that Blocks Anti-CD41 Binding
The density of glycoprotein receptors on platelet membrane is dynamic and increase upon platelet activation by various stimulants to facilitate more ligand binding and functional outcome. Since CD41/61 receptor complex i...
Comparison Effect of Moringa oleifera Leaf Meal and Oxytetracycline on Haematology and Serum Biochemical Profile of Broiler Finishers
Aims: The study was carried out to assess the effects of Moringa oleifera leaf meal on the haematological parameters and serum biochemical profile of broiler finishers in comparison with oxytetracycline. Study Design:...
Female Contribution in Blood Donation and Alternatives: Fact & Factual
Background: Blood can neither be manufactured nor can be procured from other creatures and can only be taken from healthy human beings between the ages 18-65 years for providing safe blood/component to the needy human be...
Haematological Profile of Alloxan-induced Diabetic Rats Treated with Methanol Root Bark Extract of Cussonia arborea
The study was tailored to investigate changes in all haematological parameters of diabetic rats treated with methanol root bark extract of Cussonia arborea. A total of 72 male albino wistar rats assigned into 6 groups of...